VDAART FLORA ANCILLARY STUDY

VDAART 植物群辅助研究

基本信息

  • 批准号:
    8448671
  • 负责人:
  • 金额:
    $ 40.07万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-04-01 至 2016-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Asthma is the most common cause of chronic childhood disease in the United States, and is a major health problem, particularly in urban pediatric populations. Most asthma is diagnosed before the age of six, and most children with asthma are atopic with sensitization to at least one allergen. Bacterial gut colonization and Vitamin D exposure are two factors that vary in children with urbanization, may influence immune function at the intestinal and systemic levels, and may increase the risk of allergy and asthma. In a small pilot study we found that the anti-inflammatory immunomodulatory cytokine IL-10 was increased in the cord blood of children whose mothers had a higher proportion of anaerobes in the gut. Infant gut diversity was protective against atopic dermatitis in the first 6 months of life. However, there has been no adequate long-term follow-up study of the gut flora in human early life and the development of atopic diseases. In the only U.S. pre-birth Vitamin D asthma intervention trial (NIH Grant number: U01 HL091528, co-PIs: Litonjua & Weiss), we have a unique opportunity to evaluate the influences of gut colonization (maternal and child) on the risk of early life wheeze, atopic dermatitis, and allergic sensitization. Moreover, this proposed ancillary study will optimize the chance to evaluate whether gut colonization and vitamin D influences on allergy and asthma development are independent or linked. We propose to test the following primary hypotheses in a subset of 200 mother:child pairs: (1) Higher levels of maternal vitamin D during pregnancy will increase numbers of total and specific anaerobes (B fragilis, and Lactobacillus) in the maternal and child intestinal flora; (2) Increased numbers of anaerobes in the maternal intestinal flora, and in the child intestinal flora at 4 months of age will reduce the risk of wheeze, recurrent wheeze (>2 reports of wheeze in the previous year), atopic dermatitis (eczema), and sensitization to >1 allergen at 1 year of age. We will consider exposures to total anaerobes, as well as the specific anaerobes B fragilis, and Lactobacillus; To further explore whether there are common pathways through which intestinal flora and vitamin D influence allergy and wheeze, we will test the following three secondary hypotheses: 3) Higher levels of maternal vitamin D during pregnancy will reduce the risk of recurrent wheeze, atopic dermatitis and sensitization in part through increasing numbers of anaerobes in the maternal intestinal flora, and in the child intestinal flora at 4 months of age. (4) Increased numbers of total and specific anaerobes in maternal and child intestinal flora will increase the frequency and anti-inflammatory function of Foxp3+ and IL-10+ Treg cells in cord blood.(5) Maternal supplementation with vitamin D during pregnancy will increase the diversity/complexity of maternal and child fecal flora. This proposal is time-sensitive. As ascertainment of the composition of maternal intestinal flora is central to our hypotheses, it is critically important that this ancillary study be initiated early in the final year (2011) of the enrollment and delivery period of the parent clinical trial VDAART. PUBLIC HEALTH RELVEANCE: Asthma is a major public health problem and the most common cause of chronic childhood disease in the United States. Over a 40 year period, allergic asthma, allergic rhinitis (hay fever) and atopic dermatitis (atopic eczema) prevalence increased, and the high prevalence of asthma persists, particularly in urban pediatric populations in the United States. If we identify components of maternal or childhood intestinal microbial flora that are protective against allergy, wheeze or asthma, and that vary with vitamin D levels or diet, this could be translated into pharmacologic or dietary interventions that would be of great benefit to public health. (End of Abstract)
描述(由申请人提供):哮喘是美国慢性儿童疾病的最常见原因,并且是一个主要的健康问题,尤其是在城市小儿种群中。大多数哮喘是在六岁之前诊断出来的,大多数哮喘儿童都在特定于至少一种过敏原。细菌肠道定植和维生素D暴露是城市化儿童不同的两个因素,可能会影响肠道和全身水平的免疫功能,并可能增加过敏和哮喘的风险。在一项小型试点研究中,我们发现抗炎性细胞因子IL-10在肠道中母亲的厌氧菌比例较高的儿童的脐带血中增加了。婴儿肠道多样性在生命的头六个月中可防止特应性皮炎。但是,在人类早期生活和特应性疾病的发展中,没有足够的长期随访研究。在美国唯一的美国出生前维生素D哮喘干预试验(NIH赠款编号:U01 HL091528,Co-Pis:Litonjua&Weiss)中,我们有一个独特的机会来评估肠道殖民(母性和儿童)对早期生命的风险的影响,对早期生命的风险,以及patopic Dermatitis to peropic Dermatitis and Axtrergic敏感性。此外,这项拟议的辅助研究将优化评估肠道定植和维生素D对过敏和哮喘发育的影响是独立的还是相关的。我们建议在200个母亲的子集中检验以下主要假设:儿童对:(1)妊娠期间较高的母体维生素D水平将增加总数和特定的数量 孕产妇和儿童肠菌群中的厌氧菌(B fragilis和乳杆菌); (2)母体肠道菌群中的厌氧菌数量增加,在4个月时的儿童肠道菌群中,会降低喘息的风险,反复喘息的风险(>上一年喘息的报告),特应性皮炎(湿疹)(湿疹)(湿疹)和1岁时> 1个过敏原的敏感性。我们将考虑暴露于总厌氧菌以及特定的厌氧菌B fragilis和乳杆菌; To further explore whether there are common pathways through which intestinal flora and vitamin D influence allergy and wheeze, we will test the following three secondary hypotheses: 3) Higher levels of maternal vitamin D during pregnancy will reduce the risk of recurrent wheeze, atopic dermatitis and sensitization in part through increasing numbers of anaerobes in the maternal intestinal flora, and in the child intestinal flora at 4 months of age. (4)母亲和儿童肠道菌群中总数和特异性厌氧菌数量增加将增加脐带血中Foxp3+和IL-10+ Treg细胞的频率和抗炎功能。(5)怀孕期间用维生素D补充孕妇会增加母体和儿童的多样性/复杂性。该建议对时间敏感。由于确定母体肠道菌群的组成是我们假设的核心,因此在父母临床试验VDAART的入学和分娩期的最后一年(2011年)开始,这项辅助研究至关重要。公共卫生复制:哮喘是美国慢性儿童疾病的最常见原因。在40年内,过敏性哮喘,过敏性鼻炎(花粉症)和特应性皮炎(特应性湿疹)的患病率增加,并且哮喘的高患病率持续存在,特别是在美国城市小儿种群中。如果我们确定可抵抗过敏,喘息或哮喘的孕产妇或儿童肠道微生物菌群的组成部分,并且随维生素D水平或饮食的变化而变化,则可以将其转化为对公共卫生有很大益处的药理或饮食干预措施。 (抽象的结尾)

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Longitudinal Prediction of the Infant Gut Microbiome with Dynamic Bayesian Networks.
  • DOI:
    10.1038/srep20359
  • 发表时间:
    2016-02-08
  • 期刊:
  • 影响因子:
    4.6
  • 作者:
    McGeachie MJ;Sordillo JE;Gibson T;Weinstock GM;Liu YY;Gold DR;Weiss ST;Litonjua A
  • 通讯作者:
    Litonjua A
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DIANE R GOLD其他文献

DIANE R GOLD的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DIANE R GOLD', 18)}}的其他基金

Cardiovascular Response to CAP Microbial Components in Controlled Human Exposures
在受控人体暴露中对 CAP 微生物成分的心血管反应
  • 批准号:
    8805972
  • 财政年份:
    2015
  • 资助金额:
    $ 40.07万
  • 项目类别:
Cardiovascular Response to CAP Microbial Components in Controlled Human Exposures
在受控人体暴露中对 CAP 微生物成分的心血管反应
  • 批准号:
    8995662
  • 财政年份:
    2015
  • 资助金额:
    $ 40.07万
  • 项目类别:
The Fetal and Childhood Environment, Oxidative Balance, Inflammation and Asthma
胎儿和童年环境、氧化平衡、炎症和哮喘
  • 批准号:
    9057454
  • 财政年份:
    2013
  • 资助金额:
    $ 40.07万
  • 项目类别:
The Fetal and Childhood Environment, Oxidative Balance, Inflammation and Asthma
胎儿和童年环境、氧化平衡、炎症和哮喘
  • 批准号:
    9278076
  • 财政年份:
    2013
  • 资助金额:
    $ 40.07万
  • 项目类别:
The Fetal and Childhood Environment, Oxidative Balance, Inflammation and Asthma
胎儿和童年环境、氧化平衡、炎症和哮喘
  • 批准号:
    8584430
  • 财政年份:
    2013
  • 资助金额:
    $ 40.07万
  • 项目类别:
The Fetal and Childhood Environment, Oxidative Balance, Inflammation and Asthma
胎儿和童年环境、氧化平衡、炎症和哮喘
  • 批准号:
    8685884
  • 财政年份:
    2013
  • 资助金额:
    $ 40.07万
  • 项目类别:
The Fetal and Childhood Environment, Oxidative Balance, Inflammation and Asthma
胎儿和童年环境、氧化平衡、炎症和哮喘
  • 批准号:
    8851510
  • 财政年份:
    2013
  • 资助金额:
    $ 40.07万
  • 项目类别:
VDAART FLORA ANCILLARY STUDY
VDAART 植物群辅助研究
  • 批准号:
    8152908
  • 财政年份:
    2011
  • 资助金额:
    $ 40.07万
  • 项目类别:
Climate Change and Cardiac Vulnerability in Humans
气候变化和人类心脏脆弱性
  • 批准号:
    8152632
  • 财政年份:
    2011
  • 资助金额:
    $ 40.07万
  • 项目类别:
Climate Change and Cardiac Vulnerability in Humans
气候变化和人类心脏脆弱性
  • 批准号:
    8309282
  • 财政年份:
    2011
  • 资助金额:
    $ 40.07万
  • 项目类别:

相似国自然基金

3-6岁人工耳蜗植入儿童汉语句法习得机制
  • 批准号:
    32371110
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目
3-6岁学龄前儿童碘膳食参考摄入量的研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    52 万元
  • 项目类别:
    面上项目
3-6岁学龄前儿童碘膳食参考摄入量的研究
  • 批准号:
    82273629
  • 批准年份:
    2022
  • 资助金额:
    52.00 万元
  • 项目类别:
    面上项目
3-6岁儿童情绪调节能力的追踪研究:亲子互动同步性与儿童气质的共同作用
  • 批准号:
  • 批准年份:
    2021
  • 资助金额:
    56 万元
  • 项目类别:
    面上项目
3-6岁儿童情绪调节能力的追踪研究:亲子互动同步性与儿童气质的共同作用
  • 批准号:
    32171067
  • 批准年份:
    2021
  • 资助金额:
    56.00 万元
  • 项目类别:
    面上项目

相似海外基金

Effects of Nicotine Concentration Levels in E-cigarettes on Biomarkers of Exposure to Toxicants and Tobacco Use Behaviors
电子烟中尼古丁浓度水平对有毒物质暴露和烟草使用行为生物标志物的影响
  • 批准号:
    10678555
  • 财政年份:
    2023
  • 资助金额:
    $ 40.07万
  • 项目类别:
Predictive ability of early somatosensory processing in preterm children on later motor development
早产儿早期体感处理对后期运动发育的预测能力
  • 批准号:
    10638542
  • 财政年份:
    2023
  • 资助金额:
    $ 40.07万
  • 项目类别:
Effects of Early Life Exposure to Household Air Pollution on DNA Methylation and Respiratory Disease in Guatemalan Children from the Household Air Pollution Intervention Network (HAPIN) Trial
根据家庭空气污染干预网络 (HAPIN) 试验,生命早期接触家庭空气污染对危地马拉儿童 DNA 甲基化和呼吸道疾病的影响
  • 批准号:
    10660568
  • 财政年份:
    2023
  • 资助金额:
    $ 40.07万
  • 项目类别:
Milk Type in Toddlers (Milk-TOT) Study: Impact of Whole versus Low-fat Milk on Child Adiposity, Health and Development
幼儿牛奶类型 (Milk-TOT) 研究:全脂牛奶与低脂牛奶对儿童肥胖、健康和发育的影响
  • 批准号:
    10735791
  • 财政年份:
    2023
  • 资助金额:
    $ 40.07万
  • 项目类别:
Parsing cholesterol metabolite regulation of skin immunocytes in children to identify archetypes of human neonatal immune system
解析儿童皮肤免疫细胞的胆固醇代谢调节,以确定人类新生儿免疫系统的原型
  • 批准号:
    10435128
  • 财政年份:
    2022
  • 资助金额:
    $ 40.07万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了